Gene expression analysis of kidneys from transgenic mice expressing fibroblast growth factor-23

Nephrology Dialysis Transplantation

Volumn 23, Issue 3, 2008, Pages 827-833

  Marsell, Richard ^a   Krajisnik, Tijana ^a   Göransson, Hanna ^a   Ohlsson, Claes ^b   Ljunggren, Östen ^a   Larsson, Tobias E ^a   Jonsson, Kenneth B ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Atp1a1; Atp1a2; FGF 23; Klotho; Phosphate

Indexed keywords

CALCIUM; COLLAGEN TYPE 1; FIBROBLAST GROWTH FACTOR 23; GENE PRODUCT; KLOTHO PROTEIN; PHOSPHATE; PROTEIN ATP1A1; PROTEIN ATP1A2; PROTEIN PDZK1; SECRETED FRIZZLED RELATED PROTEIN 4; SODIUM HYDROGEN EXCHANGER REGULATORY FACTOR 1; SODIUM PHOSPHATE COTRANSPORTER 2A; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ATP1A2 PROTEIN, MOUSE; FIBROBLAST GROWTH FACTOR; MESSENGER RNA; PDZK1 PROTEIN, MOUSE; PHOSPHOPROTEIN; SIGNAL PEPTIDE; SLC34A1 PROTEIN, MOUSE; SODIUM HYDROGEN EXCHANGER REGULATORY FACTOR; SODIUM PROTON EXCHANGE PROTEIN; SODIUM-HYDROGEN EXCHANGER REGULATORY FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CALCIUM METABOLISM; GENE EXPRESSION REGULATION; KIDNEY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; HOMEOSTASIS; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CALCIUM; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION PROFILING; HOMEOSTASIS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; MICE; MICE, TRANSGENIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHATES; PHOSPHOPROTEINS; RNA, MESSENGER; SODIUM-HYDROGEN ANTIPORTER; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE IIA; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 42449126730     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm672     Document Type: Article

References (29)

1. Liu S, Quarles LD. How fibroblast growth factor 23 works. J Am Soc Nephrol 2007; 18: 1637-1647.
2. Larsson T, Marsell R, Schipani E et al. Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. Endocrinology 2004; 145: 3087-3094
3. Sitara D, Razzaque MS, Hesse M et al. Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol 2004; 23: 421-432
4. Riminucci M, Collins MT, Fedarko NS et al. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 2003; 112: 683-692
5. Bai X, Miao D, Li J et al. Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders. Endocrinology 2004; 145: 5269-5279
6. Shimada T, Urakawa I, Yamazaki Y et al. FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa. Biochem Biophys Res Commun 2004; 314: 409-414
7. Urakawa I, Yamazaki Y, Shimada T et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 2006; 444: 770-774
8. Razzaque MS, Sitara D, Taguchi T et al. Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process. Faseb J 2006; 20: 720-722
9. Ameur A, Yankovski V, Enroth S et al. The LCB data warehouse. Bioinformatics 2006; 22: 1024-1026
10. Gisler SM, Madjdpour C, Bacic D et al. PDZK1: II. an anchoring site for the PKA-binding protein D-AKAP2 in renal proximal tubular cells. Kidney Int 2003; 64: 1746-1754
11. Imura A, Tsuji Y, Murata M et al. alpha-Klotho as a regulator of calcium homeostasis. Science 2007; 316: 1615-1618
12. Mishra J, Mori K, Ma Q et al. Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 2004; 15: 3073-3082
13. Cano NJ. Metabolism and clinical interest of serum transthyretin (prealbumin) in dialysis patients. Clin Chem Lab Med 2002; 40: 1313-1319
14. Shimada T, Hasegawa H, Yamazaki Y et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 2004; 19: 429-435
15. Meyer MH, Dulde E, Meyer RA Jr. The genomic response of the mouse kidney to low-phosphate diet is altered in X-linked hypophosphatemia. Physiol Genom 2004; 18: 4-11
16. Jonsson KB, Zahradnik R, Larsson T et al. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 2003; 348: 1656-1663
17. Yu X, Ibrahimi OA, Goetz R et al. Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23. Endocrinology 2005; 146: 4647-4656
18. Fukuda T, Kanomata K, Nojima J et al. FGF23 induces expression of two isoforms of NAB2, which are corepressors of Egr-1. Biochem Biophys Res Commun 2007; 353: 147-151
19. Hernando N, Deliot N, Gisler SM et al. PDZ-domain interactions and apical expression of type IIa Na/P(i) cotransporters. Proc Natl Acad Sci USA 2002; 99: 11957-11962
20. Shenolikar S, Voltz JW, Minkoff CM et al. Targeted disruption of the mouse NHERF-1 gene promotes internalization of proximal tubule sodium-phosphate cotransporter type IIa and renal phosphate wasting. Proc Natl Acad Sci USA 2002; 99: 11470-11475
21. Capuano P, Bacic D, Roos M et al. Defective coupling of apical PTH - receptors to phospholipase C prevents internalization of the Na+/phosphate cotransporter NaPi-IIa in NHERF1 deficient mice. Am J Physiol Cell Physiol 2007; 292: 927-34
22. Custer M, Spindler B, Verrey F et al. Identification of a new gene product (diphor-1) regulated by dietary phosphate. Am J Physiol 1997; 273: F801-F806
23. Kocher O, Pal R, Roberts M et al. Targeted disruption of the PDZK1 gene by homologous recombination. Mol Cell Biol 2003; 23: 1175-1180
24. Capuano P, Bacic D, Stange G et al. Expression and regulation of the renalNa/phosphate cotransporter NaPi-IIa in amousemodel deficient for the PDZ protein PDZK1. Pflugers Arch 2005; 449: 392-402
25. Hesse M, Frohlich LF, Zeitz U et al. Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice. Matrix Biol 2007; 26: 75-84
26. Kurosu H, Yamamoto M, Clark JD et al. Suppression of aging in mice by the hormone Klotho. Science 2005; 309: 1829-1833
27. Berner YN, Shike M. Consequences of phosphate imbalance. Annu Rev Nutr 1988; 8: 121-148
28. Larsson T, Nisbeth U, Ljunggren O et al. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 2003; 64: 2272-2279
29. Jonsson KB. The role of fibroblast growth factor 23 in renal disease. Nephrol Dial Transplant 2005; 20: 479-482